Published in Circulation on June 12, 2006
Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J Am Coll Cardiol (2010) 3.18
ICD programming. Indian Heart J (2013) 2.00
Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. JAMA (2013) 1.51
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. J Arrhythm (2016) 0.88
ICD discrimination of SVT versus VT with 1:1 V-A conduction: A review of the literature. Indian Pacing Electrophysiol J (2016) 0.88
Future Research Prioritization: Implantable Cardioverter-Defibrillator Therapy in Older Patients. J Gen Intern Med (2015) 0.87
Implantable cardioverter defibrillator therapy: a single center experience in saudi arabia. Open Cardiovasc Med J (2010) 0.82
Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study. Clin Res Cardiol (2015) 0.81
Programming implantable cardioverter/defibrillators and outcomes. F1000Prime Rep (2015) 0.80
Overview of implantable cardioverter defibrillator and cardiac resynchronisation therapy in heart failure management. Singapore Med J (2016) 0.78
Strategic choices to reduce implantable cardioverter-defibrillator-related morbidity. Nat Rev Cardiol (2010) 0.77
Sleep-disordered breathing and inappropriate defibrillator shocks in chronic heart failure. Herzschrittmacherther Elektrophysiol (2014) 0.76
Are dual-chamber implantable cardioverter-defibrillators really better than single-chamber ones? A systematic review and meta-analysis. J Interv Card Electrophysiol (2014) 0.75
Troubleshooting implantable cardioverter-defibrillators: an overview for physicians who are not electrophysiologists. Tex Heart Inst J (2011) 0.75
Relation between detection rate and inappropriate shocks in single versus dual chamber cardioverter-defibrillator - an analysis from the OPTION trial. Sci Rep (2016) 0.75
Overcoming the defects of a virtue: dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Circulation (2006) 0.75
Integrated approach for smart implantable cardioverter defibrillator (ICD) device with real time ECG monitoring: use of flexible sensors for localized arrhythmia sensing and stimulation. Front Physiol (2013) 0.75
Inappropriate shocks in patients with ICDs: single chamber versus dual chamber. Arq Bras Cardiol (2013) 0.75
Polymorphisms in the GNAS Gene as Predictors of Ventricular Tachyarrhythmias and Sudden Cardiac Death: Results From the DISCOVERY Trial and Oregon Sudden Unexpected Death Study. J Am Heart Assoc (2016) 0.75
Outcomes of single- or dual-chamber implantable cardioverter defibrillator systems in Japanese patients. J Arrhythm (2015) 0.75
"Two for the Price of One": A Single-Lead Implantable Cardioverter-Defibrillator System with a Floating Atrial Dipole. J Atr Fibrillation (2016) 0.75
Device Management in Heart Failure. Curr Cardiol Rep (2017) 0.75
[Sandwiched between the single- and triple-chamber ICD: do we still need the dual-chamber ICD?]. Herzschrittmacherther Elektrophysiol (2008) 0.75
Influence of myopotential interference on the Wavelet discrimination algorithm in implantable cardioverter-defibrillator. J Arrhythm (2016) 0.75
Effect of supplemented intake of omega-3 fatty acids on arrhythmias in patients with ICD: fish oil therapy may reduce ventricular arrhythmia. J Interv Card Electrophysiol (2017) 0.75
[Inappropriate ICD therapies: All problems solved with MADIT-RIT?]. Herzschrittmacherther Elektrophysiol (2015) 0.75
Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA (2010) 8.90
Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med (2012) 8.84
Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA (2012) 6.29
Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA (2003) 5.30
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol (2008) 4.63
Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation (2008) 4.43
An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann Intern Med (2015) 4.18
Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation (2007) 3.90
Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol (2009) 3.73
Catheter ablation for atrial fibrillation. N Engl J Med (2011) 3.61
Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol (2004) 3.49
Validation of a new coma scale: The FOUR score. Ann Neurol (2005) 3.39
Clinical Review. Personality disorder. BMJ (2013) 3.27
Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med (2002) 3.17
J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance. J Am Coll Cardiol (2008) 2.87
Electrophysiologic characteristics of ventricular arrhythmias arising from the aortic mitral continuity-potential role of the conduction system. J Cardiovasc Electrophysiol (2015) 2.73
The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA). JACC Cardiovasc Imaging (2010) 2.69
Net reclassification indices for evaluating risk prediction instruments: a critical review. Epidemiology (2014) 2.67
Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum (2003) 2.62
Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology (2008) 2.58
No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial. Br J Nutr (2007) 2.57
The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. J Am Coll Cardiol (2010) 2.56
Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging (2009) 2.51
No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: results from a community-based study. Arthritis Rheum (2004) 2.48
Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study. Pain (2003) 2.44
Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction: the multicenter thermocool ventricular tachycardia ablation trial. Circulation (2008) 2.38
Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study. Arch Neurol (2004) 2.37
Opportunity cost of antidepressant prescribing in England: analysis of routine data. BMJ (2005) 2.35
A qualitative study exploring how GPs decide to prescribe antidepressants. Br J Gen Pract (2005) 2.31
High-sensitivity C-reactive protein as an independent predictor of progressive myocardial functional deterioration: the multiethnic study of atherosclerosis. Am Heart J (2012) 2.18
The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol (2010) 2.15
Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells. J Am Coll Cardiol (2012) 2.13
Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration. Heart Rhythm (2006) 2.13
Evaluating the incremental value of new biomarkers with integrated discrimination improvement. Am J Epidemiol (2011) 2.09
Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. Am J Clin Nutr (2006) 2.04
Syncope Evaluation in the Emergency Department Study (SEEDS): a multidisciplinary approach to syncope management. Circulation (2004) 2.04
Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients. J Am Coll Cardiol (2005) 2.03
Effect of pacing method on risk of sudden death after atrioventricular node ablation and pacemaker implantation in patients with atrial fibrillation. Heart Rhythm (2013) 1.99
"Medication career" or "moral career"? The two sides of managing antidepressants: a meta-ethnography of patients' experience of antidepressants. Soc Sci Med (2008) 1.92
Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med (2010) 1.88
Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke (2004) 1.88
Is idiopathic ventricular fibrillation a short QT syndrome? Comparison of QT intervals of patients with idiopathic ventricular fibrillation and healthy controls. Heart Rhythm (2004) 1.86
Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum (2008) 1.79
Same-segment and adjacent-segment disease following posterior cervical foraminotomy. J Neurosurg Spine (2007) 1.75
Lower extremity peripheral artery disease in the absence of traditional risk factors. The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis (2010) 1.71
Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J (2009) 1.71
The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias. J Am Coll Cardiol (2007) 1.69
Mortality of heart failure patients after cardiac resynchronization therapy: identification of predictors. J Cardiovasc Electrophysiol (2008) 1.69
The natural history of lone atrial flutter. Ann Intern Med (2004) 1.68
The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol (2006) 1.68
Use of cerebrospinal fluid flow rates measured by phase-contrast MR to predict outcome of ventriculoperitoneal shunting for idiopathic normal-pressure hydrocephalus. Mayo Clin Proc (2002) 1.62
Relationship between baseline coronary calcium score and demonstration of coronary artery stenoses during follow-up MESA (Multi-Ethnic Study of Atherosclerosis). JACC Cardiovasc Imaging (2009) 1.62
Left atrial contractile function following a successful modified Maze procedure at surgery and the risk for subsequent thromboembolic stroke. J Am Coll Cardiol (2011) 1.62
Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol (2008) 1.61
Electrogram characteristics in postinfarction ventricular tachycardia: effect of infarct age. J Am Coll Cardiol (2005) 1.60
A novel mutation in the HCN4 gene causes symptomatic sinus bradycardia in Moroccan Jews. J Cardiovasc Electrophysiol (2010) 1.60
Pacemakers and magnetic resonance imaging: no longer an absolute contraindication when scanned correctly. Isr Med Assoc J (2010) 1.59
Misdiagnosis of atrial fibrillation and its clinical consequences. Am J Med (2004) 1.58
Relationship of interleukin-6 with regional and global left-ventricular function in asymptomatic individuals without clinical cardiovascular disease: insights from the Multi-Ethnic Study of Atherosclerosis. Eur Heart J (2010) 1.58
Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch Intern Med (2008) 1.57
Intrinsic contribution of gender and ethnicity to normal ankle-brachial index values: the Multi-Ethnic Study of Atherosclerosis (MESA). J Vasc Surg (2007) 1.57
Clinical effectiveness of collaborative care for depression in UK primary care (CADET): cluster randomised controlled trial. BMJ (2013) 1.56
Myocardium of the superior vena cava, coronary sinus, vein of Marshall, and the pulmonary vein ostia: gross anatomic studies in 620 hearts. J Cardiovasc Electrophysiol (2012) 1.55
Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia. Circulation (2007) 1.55
Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls. PLoS One (2011) 1.55
Selective peripheral denervation for the treatment of intractable spasmodic torticollis: experience with 168 patients at the Mayo Clinic. J Neurosurg (2003) 1.53
Effect of bundle branch block patterns on mortality in hospitalized patients with heart failure. Am J Cardiol (2008) 1.53
Analysis of tumor-associated stromal cells using SCID GFP transgenic mice: contribution of local and bone marrow-derived host cells. FASEB J (2006) 1.52
Race/ethnicity and the incidence of new-onset atrial fibrillation after isolated coronary artery bypass surgery. Heart Rhythm (2010) 1.51
A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs. Cardiovasc Res (2004) 1.49
Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res (2008) 1.49
The presence of tandem endothelial nitric oxide synthase gene polymorphisms identifying brain aneurysms more prone to rupture. J Neurosurg (2005) 1.49
Mitochondrial genetic polymorphisms and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev (2007) 1.48
Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillator. Heart Rhythm (2010) 1.47
Cardiac resynchronization therapy in patients with right ventricular pacing-induced cardiomyopathy. Pacing Clin Electrophysiol (2009) 1.46
Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: a double-blind, placebo-controlled, randomized trial. Heart Rhythm (2011) 1.46
Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene. Heart Rhythm (2011) 1.46
Predictors and course of high-degree atrioventricular block after transcatheter aortic valve implantation using the CoreValve Revalving System. Am J Cardiol (2011) 1.45
Cost-effectiveness of cognitive-behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: economic evaluation of the CoBalT Trial. Br J Psychiatry (2013) 1.44
Arrhythmogenicity of weight-loss supplements marketed on the Internet. Heart Rhythm (2009) 1.43
Nucleotide excision repair pathway polymorphisms and pancreatic cancer risk: evidence for role of MMS19L. Cancer Epidemiol Biomarkers Prev (2009) 1.43
Response to cardiac resynchronization therapy predicts survival in heart failure: a single-center experience. J Cardiovasc Electrophysiol (2007) 1.43
Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator. J Cardiovasc Electrophysiol (2013) 1.42
Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events. Mayo Clin Proc (2006) 1.42
Electrophysiological testing and ablation in an asymptomatic child with Wolff-Parkinson-White syndrome. Isr Med Assoc J (2010) 1.41
Functional response to cardiac resynchronization therapy in patients with renal dysfunction and subsequent long-term mortality. J Cardiovasc Electrophysiol (2014) 1.41
Variability in post-pacing intervals predicts global atrial activation pattern during tachycardia. J Cardiovasc Electrophysiol (2007) 1.40
What's your best time? Chronometry in the learning of medical procedures. Med Educ (2014) 1.40
Use of an autologous blood recovery system during emergency pericardiocentesis in the electrophysiology laboratory. J Cardiovasc Electrophysiol (2009) 1.40
Effect of radiofrequency ablation of atrial flutter on the natural history of subsequent atrial arrhythmias. J Cardiovasc Electrophysiol (2008) 1.40
Interatrial conduction measured during biventricular pacemaker implantation accurately predicts optimal paced atrioventricular intervals. J Cardiovasc Electrophysiol (2007) 1.40
Variability in postpacing intervals predicts global ventricular activation pattern during tachycardia. Pacing Clin Electrophysiol (2009) 1.39
Programming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: results from the PROVE trial. J Cardiovasc Electrophysiol (2010) 1.39
Clinical presentation, investigation, and management of pulmonary vein stenosis complicating ablation for atrial fibrillation. Circulation (2005) 1.38